Updated weekly. Details via Crossref

Crossref	Scopus	Google Scholar
5	5	Search

2026	Therapeutic horizons in the development of PROTAC-based EZH2 inhibitors: recent achievements, comparative analysis, and future perspectives RSC Advances Hamada S. Abulkhair
2025	What Every Pediatric Surgeon Should Know About Common Systemic Therapies for the Treatment of Renal Tumors in Children and Adolescents Journal of Pediatric Surgery Alicia D. Menchaca, Shachi Srivatsa, Kathleen Kieran, Elizabeth Fialkowski, Alex Soto, Elisabeth T. Tracy, Rodrigo LP. Romao, Meera Kotagal, Marcus M. Malek, Andrew J. Murphy, Richard D. Glick, Amy Armstrong, Nicholas G. Cost, Jennifer H. Aldrink
2025	GSK343, an inhibitor of EZH2, prevents acquired cisplatin resistance in bladder cancer Molecular Genetics and Genomics Liang He, Peng Liu
2025	RNA Epigenetics in Cancer: Current Knowledge and Therapeutic Implications MedComm Shanhe Huang, Zonglin Li, Weilong Lin, Ruihui Xie, Hai Huang
	Additional cited-by details will be shown when available from Crossref